e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Miscellaneous lower respiratory tract infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antimycobacterial and antipseudomonas drug from
allium ascalonicum
M. Amin, M. A. Tabee (Ahwaz, Islamic Republic Of Iran)
Source:
Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Session:
Miscellaneous lower respiratory tract infections
Session type:
Thematic Poster Session
Number:
3909
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Amin, M. A. Tabee (Ahwaz, Islamic Republic Of Iran). Antimycobacterial and antipseudomonas drug from
allium ascalonicum
. Eur Respir J 2007; 30: Suppl. 51, 3909
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
A novel mucoactive herbal drug, radix ophiopogonis
Source: Eur Respir J 2002; 20: Suppl. 38, 283s
Year: 2002
Cough suppresive and bronchodilatory activities of polysaccharides isolated from the malian medicinal plants
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
Anti-oxidative and anti-inflammatory effects of trigonella foenum graecum (fenugreek) seed extract in experimental pulmonary fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Anti-tuberculosis drugs
Source: International Congress 2017 – State of the art session: "Respiratory infections"
Year: 2017
Assessment of anti-tuberculosis activity of extracts of cinnamomum verum and solanun surattense along with isoniazid
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Anticancer and cancer prevention effects of
toona sinensis
leaf extract in human NSCLC cell
Source: Eur Respir J 2006; 28: Suppl. 50, 388s
Year: 2006
Anti-fibrotic and antioxidant effects of Ailanthus altissima wood aqueous extract against bleomycin-induced lung fibrosis in rat
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017
A combination of thyme and primula dry extracts possesses antitussive activity and inhibits leukotriene formation
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
In vitro antibacterial activity bark‘s extracts of populus tremula L
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Macrolides as anti-inflammatory agents in CAP
Source: Eur Respir Monogr 2014; 63: 243-255
Year: 2014
In silico validation of anti-tuberculosis activity and identification of lead molecules in Annona squamosa
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019
The prophylactic effect of
Nigella sativa
on asthma disease
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Drug resistant pattern of antitubercular drugs in India
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
Effect of flavonoids extracted from
Cleome Arabica
on human neutrophil elastase activity
Source: Eur Respir J 2006; 28: Suppl. 50, 662s
Year: 2006
In-vitro bronchodilator activity clitoria ternatea and A. precatorius
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Initial antituberculosis drugs resistance
Source: Eur Respir J 2006; 28: Suppl. 50, 12s
Year: 2006
Anti-inflammatory, antioxidant and immunomodulatory effects of curcumin in sensitized rat
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017
Novel anti-inflammatory agents
Source: Annual Congress 2009 - Emerging trends in the therapy of COPD
Year: 2009
Cardiotoxicity of a complex of anti-tuberculosis drugs with the inclusion of fluoroquinolones and bedaquiline in an experiment on rats
Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection
Year: 2021
Anti-inflammatory treatment
Source: International Congress 2017 – PG3 Bronchiectasis
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept